Germline RBBP6 mutations in familial myeloproliferative neoplasms.

导出 OA

翻译打印收藏纠错

第一作者： Ashot S,Harutyunyan

第一单位： CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;

作者： Ashot S,Harutyunyan ^[1] ; Roberto,Giambruno ^[1] ; Christian,Krendl ^[1] ; Alexey,Stukalov ^[1] ; Thorsten,Klampfl ^[1] ; Tiina,Berg ^[1] ; Doris,Chen ^[1] ; Jelena D,Milosevic Feenstra ^[1] ; Roland,Jäger ^[1] ; Bettina,Gisslinger ^[2] ; Heinz,Gisslinger ^[2] ; Elisa,Rumi ^[3] ; Francesco,Passamonti ^[4] ; Daniela,Pietra ^[3] ; André C,Müller ^[1] ; Katja,Parapatics ^[1] ; Florian P,Breitwieser ^[1] ; Richard,Herrmann ^[5] ; Jacques,Colinge ^[1] ; Keiryn L,Bennett ^[1] ; Giulio,Superti-Furga ^[1] ; Mario,Cazzola ^[3] ; Emma,Hammond ^[6] ; Robert,Kralovics ^[7]

作者单位： CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; ^[1] Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria; ^[2] Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy; ^[3] Department of Internal Medicine, Division of Hematology, University Hospital, Ospedale di Circolo, Varese, Italy; ^[4] School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia; and. ^[5] Institute of Immunology and Infectious Diseases, Murdoch University, Perth, Australia. ^[6] CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria; ^[7]